Offered by: Nemours Children's
Locations: Delaware Valley; Jacksonville, Orlando and Pensacola in Florida
A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial.
To find out if the overall dose of radiation to the brain and spine can be reduced without decreasing rates of survival in children with medulloblastoma.
> 3 and < 7 yrs of age.
Length of study is 14 months. Standard cancer care.
Trial Name: A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial
COG#: ACNS0331
(800) 354-5690 Email UsLearn more about clinical trials and get answers to questions you might have.
Go to FAQs View All Clinical TrialsNemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.